USA |NASDAQ |USD
| Report Date | Period Ending | EPS Forecast | Last Quarter's EPS | Last Year's EPS |
|---|---|---|---|---|
| Nov 9, 2022 | Sep 2022 | $0.09 | - | $0.38 |
| Report Date | Period Ending | Revenue Forecast | Last Quarter’s Revenue | Last Year’s Revenue |
|---|---|---|---|---|
| Nov 9, 2022 | Sep 2022 | $19.67M | - | $30.10M |
Co-Diagnostics, Inc's next earnings date is Wednesday, Nov 9, 2022 for the fiscal quarter ending Sep 2022.
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Sep 2022 | 3 | $0.09 | $0.02 | $0.16 |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2022 | 3 | $0.64 | $0.43 | $0.86 |
| Dec 2023 | 3 | $0.62 | $0.22 | $1.19 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Sep 2022 | 0 / 0 | $0.14 | $0.14 | $0.14 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2022 | 2 / 0 | $0.60 | $0.61 | $0.44 |
| Dec 2023 | 1 / 0 | $0.81 | $0.81 | $0.27 |
| Period End | # of Analysts | Revenue Forecast | Low Revenue Forecast | High Revenue Forecast |
|---|---|---|---|---|
| Sep 2022 | 3 | $19.67M | $18.00M | $22.00M |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2022 | 3 | $81.03M | $76.70M | $89.70M |
| Dec 2023 | 3 | $88.33M | $60.00M | $122.00M |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Aug 10, 2022 | Jun 2022 | $0.10 | - | - |
| May 12, 2022 | Mar 2022 | $0.17 | $0.34 | 100.00% |
| Mar 24, 2022 | Dec 2021 | $0.12 | $0.25 | 108.33% |
| Nov 11, 2021 | Sep 2021 | $0.21 | $0.38 | 80.95% |
| Aug 12, 2021 | Jun 2021 | $0.22 | $0.33 | 50.00% |
| May 13, 2021 | Mar 2021 | $0.20 | $0.26 | 30.00% |
| Mar 25, 2021 | Dec 2020 | $0.49 | $0.45 | -7.22% |
| Nov 16, 2020 | Sep 2020 | $0.71 | $0.53 | -24.82% |
| Aug 13, 2020 | Jun 2020 | $0.65 | $0.43 | -33.85% |
| May 14, 2020 | Mar 2020 | $-0.04 | $-0.05 | -25.00% |
| Mar 30, 2020 | Dec 2019 | $-0.09 | $-0.09 | -5.88% |
| Nov 12, 2019 | Sep 2019 | $-0.08 | $-0.10 | -33.33% |
| Aug 14, 2019 | Jun 2019 | $-0.06 | $-0.08 | -45.45% |
| May 14, 2019 | Mar 2019 | $-0.08 | $-0.09 | -12.50% |
| Dec 31, 2018 | Dec 2018 | $-0.13 | $-0.15 | -15.38% |
| Nov 14, 2018 | Sep 2018 | - | $-0.13 | - |
| Aug 10, 2018 | Jun 2018 | - | $-0.11 | - |
| May 14, 2018 | Mar 2018 | - | $-0.11 | - |
| Mar 28, 2018 | Dec 2017 | - | $-0.12 | - |
| Sep 30, 2017 | Sep 2017 | - | $-0.33 | - |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Mar 24, 2022 | Dec 2021 | $1.10 | $1.22 | 10.91% |
| Mar 25, 2021 | Dec 2020 | $1.54 | $1.36 | -11.69% |
| Mar 30, 2020 | Dec 2019 | $-0.36 | $-0.36 | - |
| Dec 31, 2018 | Dec 2018 | $-0.48 | $-0.50 | - |
| Mar 28, 2018 | Dec 2017 | - | $-0.45 | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Aug 10, 2022 | Jun 2022 | $19.67M | - | - |
| May 12, 2022 | Mar 2022 | $21.17M | $22.70M | 1.07% |
| Mar 24, 2022 | Dec 2021 | $20.91M | $20.40M | 0.98% |
| Nov 11, 2021 | Sep 2021 | $24.32M | $30.10M | 1.24% |
| Aug 12, 2021 | Jun 2021 | $27.36M | $27.36M | 1.00% |
| May 13, 2021 | Mar 2021 | $19.89M | $20.02M | 1.01% |
| Mar 25, 2021 | Dec 2020 | $24.99M | $27.15M | 1.09% |
| Nov 16, 2020 | Sep 2020 | $32.79M | $21.82M | 0.67% |
| Aug 13, 2020 | Jun 2020 | $26.45M | $24.04M | 0.91% |
| May 14, 2020 | Mar 2020 | $620.00K | $1.55M | 2.50% |
| Mar 30, 2020 | Dec 2019 | $100.00K | $108.57K | 1.09% |
| Nov 12, 2019 | Sep 2019 | $310.00K | $41.43K | 0.13% |
| Aug 14, 2019 | Jun 2019 | $520.00K | $61.57K | 0.12% |
| May 14, 2019 | Mar 2019 | $4.00K | $10.82K | 2.71% |
| Dec 31, 2018 | Dec 2018 | $10.00K | $10.82K | 1.08% |
| Nov 14, 2018 | Sep 2018 | - | $9.70K | - |
| Aug 10, 2018 | Jun 2018 | - | $9.70K | - |
| May 14, 2018 | Mar 2018 | - | $9.70K | - |
| Mar 28, 2018 | Dec 2017 | - | $2.60K | - |
| Sep 30, 2017 | Sep 2017 | - | $2.60K | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Mar 24, 2022 | Dec 2021 | $98.39M | $97.89M | -0.51% |
| Mar 25, 2021 | Dec 2020 | $72.37M | $74.55M | 3.02% |
| Mar 30, 2020 | Dec 2019 | $210.00K | $214.97K | 2.37% |
| Dec 31, 2018 | Dec 2018 | $40.00K | $39.91K | -0.22% |
| Mar 28, 2018 | Dec 2017 | - | $7.66K | - |
CODX's next earnings date is Wednesday, Nov 9, 2022 for the fiscal quarter ending Sep 30, 2022.
According to analysts, the average EPS estimation for Co-Diagnostics, Inc's next quarterly earnings is $0.09, with a low EPS estimation of $0.02, and a high estimation of $0.16.
Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $0.14, the last 2 month trend is $0.14, and the 3 month trend is $0.14.
Based on analysts, the average revenue estimation is $19.67M, with a low revenue estimation of $18.00M, and a high estimation of $22.00M.
Co-Diagnostics, Inc's previous earnings date was Aug 10, 2022 for its fiscal quarter ended Jun 30, 2022.
Co-Diagnostics, Inc's previous annual earnings date was Mar 24, 2022 for its fiscal year ended Dec 31, 2021.
CODX's earnings per share (EPS) was $1.22, beating the consensus analysts forecast of $1.10 by 10.91% , and lower than the previous year's EPS (Dec 2020) by -10.29%.
Revenues were $97.89M, worse than the forecast of $98.39M by -0.51%, and up by 31.30% from previous year's revenue.
The company reported a net income of $36.66M, -13.70% lower than the previous year.
Co-Diagnostics, Inc reported a free cash flow of $40.41M for its fiscal year, compared to $27.39M a year ago.
